- ALSO READ
Canadian PM Justin Trudeau greets Sikhs for celebrating Bandi Chhor Divas
TDP leader Ayyanna Patrudu, his son arrested for alleged documents forgery
Hetero's Covid drug Nirmacom (generic Paxlovid) gets WHO prequalification
IMD issues alert in south coastal Andhra as cyclone 'Mandous' intensifies
Hetero acquires J&J's Telangana plant, to invest Rs 600 crore more
-
Drug maker Hetero Group will be investing Rs 1,000 crore to expand its pharmaceutical and specialist business in Andhra Pradesh, its Managaing Director Vamsi Krishna Bandi said on Saturday.
Speaking at Global Investors Summit 2023 here, he said post-Covid pandemic, more countries are looking at India as a partner of choice in pharmaceutical sector, and Andhra Pradesh is ideally placed to take advantage because of a well-established ecosystem.
"We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business. This will generate an employment of a minimum of 3,000 people," he said.
Bandi further said the USD 2.5 billion pharma group employs over 10,000 people directly and indirectly in Andhra Pradesh, and supplies about 40 per cent of global HIV medicines that are manufactured in the state.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.
Download the Business Standard App for latest Business News and Market News .
First Published: Sat, March 04 2023. 13:38 IST
RECOMMENDED FOR YOU